开放、电视胸腔镜与机器人辅助胸腔镜肺叶切除术治疗II-IIIA期非小细胞肺癌
基于美国国家癌症数据库2010至2017年II-IIIA期非小细胞肺癌(排除T4)肺叶切除患者,采用倾向性评分匹配比较开放与微创(电视胸腔镜或机器人)手术。开放与微创组30天死亡率、再入院率及总生存无显著差异,微创组中位住院时间更短;机器人较电视胸腔镜中位住院时间更短、中转开胸率更低。
要点
- 开放与微创肺叶切除治疗II-IIIA期非小细胞肺癌的总生存无显著差异。
- 微创组中位住院时间较开放组缩短(5天 vs 6天,P < .001)。
- 机器人组中位住院时间较电视胸腔镜组缩短(4天 vs 5天,P < .001),中转率更低(8.9% vs 15.9%,P < .001)。
核心结论
- II-IIIA期非小细胞肺癌开放与微创肺叶切除、电视胸腔镜与机器人肺叶切除之间长期生存无显著差异。
- 微创入路较开放入路中位住院时间缩短。
- 机器人入路较电视胸腔镜入路中位住院时间缩短且中转率降低。
研究设计与样本
- 基于美国国家癌症数据库2010至2017年II-IIIA期非小细胞肺癌(排除T4)接受开放或微创肺叶切除患者的倾向性评分匹配分析。
- 开放与微创匹配队列各4652例;电视胸腔镜与机器人匹配队列各1186例。
主要发现
- 开放与微创匹配分析:微创组中位住院时间5天 vs 开放组6天(P < .001)。
- 开放与微创组30天死亡率、30天再入院率及总生存无显著差异。
- 电视胸腔镜与机器人匹配分析:机器人组中位住院时间4天 vs 电视胸腔镜组5天(P < .001)。
- 机器人组中转率8.9% vs 电视胸腔镜组15.9%(P < .001)。
- 电视胸腔镜与机器人组30天死亡率、30天再入院率及总生存无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compares the short- and long-term outcomes of open vs robotic vs video-assisted thoracoscopic surgery (VATS) lobectomy for stage II-IIIA non-small-cell lung cancer (NSCLC). METHODS: Outcomes of patients with stage II-IIIA NSCLC (excluding T4 tumors) who received open and minimally invasive surgery (MIS) lobectomy in the National Cancer Database from 2010 to 2017 were assessed using propensity score-matched analysis. RESULTS: A propensity score-matched analysis of 4652 open and 4652 MIS patients demonstrated a decreased median length of stay associated with MIS compared with open lobectomy (5 vs 6 days; P < .001). There were no significant differences in 30-day mortality, 30-day readmission, or overall survival between the open and MIS groups. A propensity score-matched analysis of 1186 VATS and 1186 robotic patients showed that compared with VATS, the robotic approach was associated with no significant differences in 30-day mortality, 30-day readmission, and overall survival. However, the robotic group had a decreased median length of stay compared with VATS (4 vs 5 days; P < .001). The conversion rate was also significantly lower for robotic compared with VATS lobectomy (8.9% vs 15.9%, P < .001). CONCLUSIONS: No significant differences were found in long-term survival between open and MIS lobectomy and between VATS and robotic lobectomy for stage II-IIIA NSCLC. However, the MIS approach was associated with a decreased length of stay compared with the open approach. The robotic approach was associated with decreased length of stay and decreased conversion rate compared with the VATS approach.
引用
- Shagabayeva L, Fu B, Panda N, et al. Open, Video- and Robot-Assisted Thoracoscopic Lobectomy for Stage II-IIIA Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022. PMID: 35149049. doi:10.1016/j.athoracsur.2022.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。